Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 1/2010

01.08.2010 | Original Article

Patient Expectancy and Post-chemotherapy Nausea: A Meta-analysis

verfasst von: Ben Colagiuri, B.Psych, Ph.D., Robert Zachariae, M.D.Sci.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Post-chemotherapy nausea remains a significant burden to cancer patients. While some studies indicate that expecting nausea is predictive of experiencing nausea, there are a number of conflicting findings.

Purpose

The purpose of this study was to conduct a meta-analytic review to determine the strength of the relationship between expectancy and post-chemotherapy nausea.

Methods

The findings from 17 relevant studies (n = 2,400) identified through systematic searches of Medline, PsycInfo, and Cinhal were analyzed using a combination of meta-analytic techniques.

Results

Overall, there was a robust positive association between expectancy and post-chemotherapy nausea (ESr = 0.18, equivalent to Cohen’s d = 0.35), suggesting that patients with stronger expectancies experience more chemotherapy-induced nausea. Although weaker associations were found in studies employing multivariate analysis, specifically controlling for a history of nausea, and involving breast cancer patients, none of the moderators assessed were statistically significant.

Conclusions

These findings suggest that patient expectancies may contribute to post-chemotherapy nausea and that expectancy-based manipulations may provide a useful intervention strategy.
Literatur
1.
Hickok JT, Roscoe JA, Morrow GR, et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics. Cancer. 2003; 97: 2880-2886.CrossRefPubMed
2.
Roscoe JA, Hickok JT, Morrow GR. Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med. 2000; 22: 121-126.CrossRefPubMed
3.
Roscoe JA, Morrow GR, Hickok JT, Stern RM. Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage. 2000; 20: 113-121.CrossRefPubMed
4.
Carelle N, Piotto E, Bellanger A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 2002; 95: 155-163.CrossRefPubMed
5.
Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996; 7: 189-195.PubMed
6.
Klastersky J, Schimpff SC, Senn HJ. Supportive care in cancer. New York: Marcel Deckker; 1999.
7.
Ballatori E, Roila F. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes. 2003; 1: 46-58.CrossRefPubMed
8.
Ballatori E, Roila F, Ruggeri B, et al. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer. 2007; 15: 179-185.CrossRefPubMed
9.
Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H. Chemotherapy-induced nausea and vomiting: Incidence and impact on patient quality of life at community oncology settings. Support Care Cancer. 2007; 15: 497-503.CrossRefPubMed
10.
Colagiuri B, Roscoe JA, Morrow GR, et al. How do patient expectancies, quality of life, and postchemotherapy nausea interrelate? Cancer. 2008; 113: 654-661.CrossRefPubMed
11.
Lindley C, Hirsch J, O’Neill C, et al. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res. 1992; 1: 331-340.CrossRefPubMed
12.
Osoba D, Zee B, Warr D, et al. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer. 1997; 5: 307-313.CrossRefPubMed
13.
14.
Grunberg SM. Chemotherapy-induced nausea and vomiting: Prevention, detection, and treatment—how are we doing? J Support Oncol. 2004; 2: 1-10.PubMed
15.
Morrow GR, Roscoe JA, Hickok JT. Nausea and vomiting. In: Holland JC, ed. Psychooncology. New York: Oxford University Press; 1998: 476-484.
16.
Roscoe JA, Morrow GR, Colagiuri B, et al. Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer 2009:[Epub ahead of print] PMID: 19701781.
17.
Hesketh PJ, Grunberg SM, Herrstedt, et al. Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapyinduced nausea and vomiting: Effect of gender on treatment response. Support Care Cancer. 2006; 14: 354-360.CrossRefPubMed
18.
Morrow GR. The effect of susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer. 1985; 55: 2766-2770.CrossRefPubMed
19.
Jacobsen PB, Andrykowski MA, Redd WH, et al. Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer. Cancer. 1988; 61: 379-385.CrossRefPubMed
20.
Montgomery GH, Bovbjerg DH. Pre-infusion expectations predict post-treatment nausea during repeated adjuvant chemotherapy infusions for breast cancer. Br J Health Psychol. 2000; 5: 105-119.CrossRef
21.
Zachariae R, Paulsen K, Mehlsen M, et al. Chemotherapy-induced nausea, vomiting, and fatigue—the role of individual differences related to sensory perception and autonomic reactivity. Psychother Psychosom. 2007; 76: 376-384.CrossRefPubMed
22.
Andrykowski MA, Gregg ME. The role of psychological variables in post-chemotherapy nausea: Anxiety and expectation. Psychosom Med. 1992; 54: 48-58.PubMed
23.
Cassileth BR, Lusk EJ, Bodenheimer BJ, et al. Chemotherapeutic toxicity—the relationship between patients’ pretreatment expectations and posttreatment results. Am J Clin Oncol. 1985; 8: 419-425.CrossRefPubMed
24.
Roscoe JA, Bushunow P, Morrow GR, et al. Patient expectation is a strong predictor of severe nausea after chemotherapy: A University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer. 2004; 101: 2701-2708.CrossRefPubMed
25.
Booth CM, Clemons M, Dranitsaris G, et al. Chemotherapy-induced nausea and vomiting in breast cancer patients: A prospective observational study. J Support Oncol. 2007; 5: 374-380.PubMed
26.
Rhodes VA, Watson PM, McDaniel RW, Hanson BM, Johnson MH. Expectation and occurrence of postchemotherapy side effects: Nausea and vomiting. Cancer Pract. 1995; 3: 247-253.PubMed
27.
Shelke AR, Roscoe JA, Morrow GR, et al. Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: A University of Rochester Cancer Center Community Clinical Oncology Program study. J Pain Symptom Manage. 2008; 35: 381-387.CrossRefPubMed
28.
Rosenthal R, Rubin DB. r equivalent. A simple effect size indicator. Psychol Methods. 2003; 8.
29.
Higgins SC, Montgomery GH, Bovbjerg DH. Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer. 2007; 15: 171-177.CrossRefPubMed
30.
Olver IN, Taylor AE, Whitford HS. Relationships between patients’ pre-treatment expectations of toxicities and post chemotherapy experiences. Psychooncology. 2005; 14: 25-33.CrossRefPubMed
31.
Watson M, Meyer L, Thomson A, Osofsky S. Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer. 1998; 34: 831-837.CrossRefPubMed
32.
Haut MW, Beckwith BE, Laurie JA, Klatt N. Postchemotherapy nausea and vomiting in cancer patients receiving outpatient chemotherapy. J Psychosoc Oncol. 1991; 9: 117-130.CrossRef
33.
Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS. Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer. 2002; 10: 139-145.CrossRefPubMed
34.
Rosenthal R. Meta-analysis: A review. Psychosom Med. 1991; 53: 247-271.PubMed
35.
Rosenthal R. Effect size estimation, significance testing, and the file-drawer problem. J Parapsychol. 1992; 56: 57-58.
36.
Peterson RA, Brown SP. On the use of beta-coefficients in meta-analysis. J Appl Psychol. 2005; 90: 175-181.CrossRefPubMed
37.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003; 327: 557-560.CrossRef
38.
Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol. 1999; 150: 469-475.PubMed
39.
Greenland S, O’Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics. 2001; 2: 463-471.CrossRefPubMed
40.
Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: A larger survey. Can Med Assoc J. 2007; 176: 1091-1096.CrossRef
41.
Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997; 315: 629-634.
42.
Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics. 2000; 1: 247-262.CrossRefPubMed
43.
Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58: 882-893.CrossRefPubMed
44.
Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56: 455-463.CrossRefPubMed
45.
Borenstein M, Rothstein H. Comprehensive meta analysis. Eaglewood: Biostat; 2009.
46.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009; 6: e1000100.CrossRefPubMed
47.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009; 6: e1000097.CrossRefPubMed
48.
Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates; 1988.
49.
Rosenthal R. The “file-drawer problem” and tolerance for null results. Psychol Bull. 1979; 86: 638-641.CrossRef
50.
Leuebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytic review. Psychooncology. 2001; 10: 490-502.CrossRef
51.
Williams AR, Hind M, Sweeney BP, et al. The incidence and severity of postoperative nausea and vomiting in patients exposed to positive intra-operative suggestions. Anaesthesia. 1994; 49: 340-342.CrossRefPubMed
52.
Eden D, Zuk Y. Seasickness as a self-fulfilling prophecy: Raising self-efficacy to boost performance at sea. J Appl Psychol. 1995; 80: 628-635.CrossRefPubMed
Metadaten
Titel
Patient Expectancy and Post-chemotherapy Nausea: A Meta-analysis
verfasst von
Ben Colagiuri, B.Psych, Ph.D.
Robert Zachariae, M.D.Sci.
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2010
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-010-9186-4

Weitere Artikel der Ausgabe 1/2010

Annals of Behavioral Medicine 1/2010 Zur Ausgabe

Original Article

Deconstruction of Nurse-Delivered Patient Self-Management Interventions for Symptom Management: Factors Related to Delivery Enactment and Response

Original Article

Using Action Planning to Promote Exercise Behavior

Original Article

Evaluation of a Brief Web-Based Genetic Feedback Intervention for Reducing Alcohol-Related Health Risks Associated with ALDH2

Original Article

Predictors of Adherence to Supervised Exercise in Lymphoma Patients Participating in a Randomized Controlled Trial

Original Article

Multifactorial Lifestyle Interventions in the Primary and Secondary Prevention of Cardiovascular Disease and Type 2 Diabetes Mellitus—A Systematic Review of Randomized Controlled Trials

Original Article

Interest in Behavioral and Psychological Treatments Delivered Face-to-Face, by Telephone, and by Internet

Neu in den Fachgebieten Neurologie und Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

17.04.2024 | Delir nicht substanzbedingt | Nachrichten

Delir kann Demenz begünstigen

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Manche Gestagene können das Risiko für Meningeome erhöhen